The top medtech trends of 2023
The top medtech trends of 2023 included innovations such as AI and some long-awaited devices finally receiving regulatory nods.
Stay updated with breaking news from Johnson Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The top medtech trends of 2023 included innovations such as AI and some long-awaited devices finally receiving regulatory nods.
Acclarent, an Irvine-based maker of minimally invasive technologies for the ears, nose and throat sector, is being sold by parent Johnson & Johnson for $275 million to Integra LifeSciences Holdings Corp.
Construction on MPark Stage 1 began in July 2021.
News and analysis on legal developments including litigation filings, case settlements, verdicts, regulation, enforcement, legislation, corporate deals, and business of law.
Welcome to the MassDevice Fast Five medtech news podcast. Here’s what you need to know for today, December 14, 2023.